Effects of IL-1ß-Blocking Therapies in Type 2 Diabetes Mellitus: A Quantitative Systems Pharmacology Modeling Approach to Explore Underlying Mechanisms.

Palmér, R; Nyman, E; Penney, M; Marley, A; Cedersund, G; Agoram, B

Palmér, R; Nyman, E; Penney, M; Marley, A; Cedersund, G; Agoram, B.

Afiliación

Palmér R; Wolfram MathCore AB, Linköping, Sweden.
Nyman E; 1] Wolfram MathCore AB, Linköping, Sweden [2] Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
Penney M; Department of Clinical Pharmacology, Drug Metabolism, and Pharmacokinetics, MedImmune, Cambridge, UK.
Marley A; Bioscience, Astra Zeneca, Alderley Park, UK.
Cedersund G; 1] Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden [2] Department of Biomedical Engineering, Linköping University, Linköping, Sweden.
Agoram B; Department of Clinical Pharmacology, Drug Metabolism, and Pharmacokinetics, MedImmune, Cambridge, UK.

CPT Pharmacometrics Syst Pharmacol ; 3: e118, 2014 Jun 11.

Article en En | MEDLINE | ID: mdl-24918743

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: CPT Pharmacometrics Syst Pharmacol Año: 2014 Tipo del documento: Article País de afiliación: Suecia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google